391 related articles for article (PubMed ID: 29987703)
1. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
2. Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo.
Sadowski MJ; Pankiewicz J; Prelli F; Scholtzova H; Spinner DS; Kascsak RB; Kascsak RJ; Wisniewski T
Neurobiol Dis; 2009 May; 34(2):267-78. PubMed ID: 19385058
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells.
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483
[TBL] [Abstract][Full Text] [Related]
4. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
[TBL] [Abstract][Full Text] [Related]
5. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
Enari M; Flechsig E; Weissmann C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
[TBL] [Abstract][Full Text] [Related]
6. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.
Yamasaki T; Baron GS; Suzuki A; Hasebe R; Horiuchi M
Virology; 2014 Feb; 450-451():324-35. PubMed ID: 24503096
[TBL] [Abstract][Full Text] [Related]
7. Tracing conformational transition of abnormal prion proteins during interspecies transmission by using novel antibodies.
Ushiki-Kaku Y; Endo R; Iwamaru Y; Shimizu Y; Imamura M; Masujin K; Yamamoto T; Hattori S; Itohara S; Irie S; Yokoyama T
J Biol Chem; 2010 Apr; 285(16):11931-6. PubMed ID: 20177064
[TBL] [Abstract][Full Text] [Related]
8. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils.
Spinner DS; Kascsak RB; Lafauci G; Meeker HC; Ye X; Flory MJ; Kim JI; Schuller-Levis GB; Levis WR; Wisniewski T; Carp RI; Kascsak RJ
J Leukoc Biol; 2007 Jun; 81(6):1374-85. PubMed ID: 17379700
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
[TBL] [Abstract][Full Text] [Related]
11. Generation of antibodies against prion protein by scrapie-infected cell immunization of PrP(0/0) mice.
Nakamura N; Miyamoto K; Shimokawa M; Nishida N; Mohri S; Kitamoto T; Horiuchi H; Furusawa S; Matsuda H
Hybrid Hybridomics; 2003 Aug; 22(4):263-6. PubMed ID: 14511572
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of abnormal prion protein (PrP(Sc)) in murine scrapie prions determined by PrP(Sc)-specific monoclonal antibodies.
Ushiki-Kaku Y; Shimizu Y; Tabeta N; Iwamaru Y; Ogawa-Goto K; Hattori S; Yokoyama T
J Vet Med Sci; 2014 Mar; 76(2):285-8. PubMed ID: 24132297
[TBL] [Abstract][Full Text] [Related]
13. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
[TBL] [Abstract][Full Text] [Related]
14. Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane.
Goold R; McKinnon C; Rabbanian S; Collinge J; Schiavo G; Tabrizi SJ
J Cell Sci; 2013 Aug; 126(Pt 16):3552-62. PubMed ID: 23813960
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
16. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
17. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
18. Global analysis of protein degradation in prion infected cells.
Hutti CR; Welle KA; Hryhorenko JR; Ghaemmaghami S
Sci Rep; 2020 Jul; 10(1):10800. PubMed ID: 32612191
[TBL] [Abstract][Full Text] [Related]
19. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
[TBL] [Abstract][Full Text] [Related]
20. Characterization of intracellular localization of PrP(Sc) in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP.
Yamasaki T; Suzuki A; Shimizu T; Watarai M; Hasebe R; Horiuchi M
J Gen Virol; 2012 Mar; 93(Pt 3):668-680. PubMed ID: 22090211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
